We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Health Canada is proposing amendments to the Food and Drug Regulations to permit the assessment of the risks associated with the non-medicinal ingredients of Division 1 drugs
